Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 08 04:00PM ET
16.33
Dollar change
+0.04
Percentage change
0.25
%
Index- P/E- EPS (ttm)-2.22 Insider Own0.29% Shs Outstand410.80M Perf Week-4.28%
Market Cap6.71B Forward P/E16.84 EPS next Y0.97 Insider Trans0.00% Shs Float409.63M Perf Month-15.78%
Income-785.00M PEG- EPS next Q0.21 Inst Own86.49% Short Float / Ratio1.14% / 7.27 Perf Quarter-25.19%
Sales12.36B P/S0.54 EPS this Y-101.75% Inst Trans3.15% Short Interest4.66M Perf Half Y-41.66%
Book/sh10.25 P/B1.59 EPS next Y184.35% ROA-3.19% Target Price26.00 Perf Year-67.62%
Cash/sh14.88 P/C1.10 EPS next 5Y- ROE-17.53% 52W Range16.04 - 54.48 Perf YTD-67.76%
Dividend6.00 P/FCF6.38 EPS past 5Y- ROI-6.65% 52W High-70.03% Beta0.88
Dividend %36.74% Quick Ratio2.28 Sales past 5Y13.61% Gross Margin15.14% 52W Low1.81% ATR0.58
Employees20041 Current Ratio2.50 Sales Q/Q-10.22% Oper. Margin7.20% RSI (14)36.65 Volatility2.08% 3.24%
OptionableYes Debt/Eq2.71 EPS Q/Q95.93% Profit Margin-6.35% Rel Volume0.82 Prev Close16.29
ShortableYes LT Debt/Eq1.80 EarningsNov 03 BMO Payout- Avg Volume641.48K Price16.33
Recom1.00 SMA20-6.67% SMA50-8.90% SMA200-46.56% Volume528,729 Change0.25%
Date Action Analyst Rating Change Price Target Change
Mar-03-17Reiterated UBS Sell $30 → $40
Aug-18-16Downgrade UBS Neutral → Sell $52 → $30
Mar-02-15Reiterated UBS Neutral $88 → $93
Jan-20-15Initiated UBS Neutral $88
Nov-26-23 06:44AM
Nov-22-23 08:42AM
Nov-16-23 04:44PM
03:48PM
Nov-15-23 11:04AM
03:09PM Loading…
Nov-13-23 03:09PM
Nov-05-23 08:44AM
Nov-03-23 11:18PM
07:30PM
12:33PM
11:24AM
11:21AM
09:47AM
08:15AM
08:00AM
03:57PM Loading…
Oct-31-23 03:57PM
Oct-26-23 06:40PM
09:16AM
07:15AM
Oct-24-23 07:07AM
Oct-17-23 10:26PM
Oct-14-23 05:30AM
Sep-28-23 11:02PM
Sep-26-23 11:04AM
Sep-25-23 06:20AM
Sep-20-23 04:22PM
10:35AM
Sep-18-23 04:30PM
Sep-16-23 02:22PM
Sep-15-23 09:41AM
09:26PM Loading…
Sep-13-23 09:26PM
03:02PM
11:03AM
Sep-07-23 05:35AM
Aug-29-23 10:43AM
07:30AM
Aug-25-23 11:01PM
Aug-24-23 03:17PM
Aug-23-23 05:02AM
Aug-22-23 11:02AM
Aug-18-23 05:27PM
Aug-15-23 04:26PM
Aug-14-23 07:01PM
Aug-13-23 05:30AM
Aug-11-23 11:02PM
Aug-10-23 08:47PM
06:12PM
05:30AM
Aug-08-23 06:37AM
Aug-07-23 12:52PM
Aug-05-23 09:14AM
Aug-04-23 11:47PM
04:54PM
04:49PM
03:01PM
12:53PM
12:45PM
12:34PM
12:17PM
12:02PM
12:00PM
11:28AM
10:53AM
10:19AM
09:57AM
08:55AM
08:22AM
08:20AM
08:13AM
08:10AM
08:04AM
08:01AM
Jul-31-23 11:58PM
Jul-28-23 07:21PM
Jul-27-23 02:00PM
Jul-25-23 06:17AM
Jul-19-23 01:41PM
Jul-17-23 04:27PM
Jul-16-23 07:48PM
Jul-11-23 05:44PM
Jul-10-23 05:32PM
05:15PM
04:30PM
04:29PM
04:27PM
04:25PM
03:10PM
02:15PM
12:29PM
12:20PM
12:05PM
11:18AM
11:13AM
10:55AM
10:49AM
10:30AM
10:00AM
09:50AM
09:44AM
09:09AM
Icahn Enterprises LP operates as holding company. It operates through following eight business segments: Investment, Automotive, Energy, Food Packaging, Metals, Real Estate, Home Fashion, and Pharma. The Investment segment consists of various private investment funds. The Automotive segment holds ownership in Icahn Automotive Group LLC. The Energy segment holds ownership in CVR Energy, Inc., which owns majority interests in two separate operating subsidiaries, CVR Refining, LP and CVR Partners, LP. The Food Packaging segment holds ownership in Viskase Cos., Inc., which is engaged in the production and sale of cellulosic, fibrous, and plastic casings for the processed meat and poultry industry. The Metals segment operates through PSC Metals, Inc., which engages in the business of collecting, processing, and selling ferrous and non-ferrous metals, as well as the processing and distribution of steel pipe and plate products in the Midwest and Southern U.S. The Real Estate segment consists of rental real estate, property development and resort activities. The Home Fashion segment operates through WestPoint Home LLC, which consists of manufacturing, sourcing, marketing, distributing, and selling home fashion consumer products. The Pharma segments operates through Vivus, Inc., a specialized pharmaceutical company. The company was founded on February 17, 1987 and is headquartered in Sunny Isles Beach, FL.